ZDZhihua Du

Zhihua Du

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhihua Du has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • scALGSL: Active Learning and Graph Structure Learning for Cell Type Annotation From Single-Cell RNA-seq Data

    by Zhi-Hua Du, Jia-Le Yi, Wei-Lin Hu, Jian-Qiang Li, Hai-Ru You, Zhu-Hong You, Zhi-An Huang, Yu-An Huang

    The breakthrough development of single cell RNA sequencing technology enables tissue hetero geneity analysis at single-cell resolution, where accurate cell type annotation is crucial for unlocking its full potential. To address three key challenges in current annotation methods—scarce labeled data, suboptimal graph topology, and missing cell state information—we propose scALGSL, an innovative framework integrating dynamic graph optimization with active learning. Our core contributions are threefold: (1) A graph guided active learning mechanism adaptively selects high-value training samples, significantly alleviating label scarcity; (2) A learnable graph structure optimization module dynamically refines adjacency matrices to eliminate spurious connections caused by data sparsity; (3) A novel cell state auxiliary pathway extracts critical functional features via pre-trained models to enhance type discrimination. The systematic review showed that the average accuracy and f1 of scALGSL on the cancer dataset were 0.896 and 0.771, respectively, and it showed good robustness in cross-platform tasks. Integration of cell state information substantially boosts performance, while ablation studies validate the necessity of node selection and edge optimization modules. This framework provides a scalable solution for precise cell annotation, facilitating tumor microenvi ronment analysis and precision medicine applications. The source code are available at: https://github.com/ an-xing456/scALGSL.

  • Open Access

    DAGFormer: A graph-based domain adaptation approach for single-cell cancer drug response prediction

    by Fen Yan, ZhiHua Du, Yu-An Huang

    Developing computational methods for single-cell drug response prediction deepens our understanding of tumor heterogeneity and uncovers resistance mechanisms critical to improving cancer therapy. However, current approaches struggle to fully capture intratumoral heterogeneity, as bulk RNA sequencing (bulk RNA-seq) obscures heterogeneity across individual cells, while single-cell RNA sequencing (scRNA-seq) remains constrained by limited throughput and high cost. Current approaches integrating bulk and scRNA-seq data frequently encounter batch effects, impairing robust knowledge transfer. Moreover, most existing methods overlook the role of intercellular interactions, treating cells as isolated entities. To overcome these limitations, we propose DAGFormer, a Graph-based Domain Adaptation framework that integrates bulk and scRNA-seq data for predicting single-cell drug responses. DAGFormer constructs cellular neighbor graphs using diverse topological strategies and employs Graph Domain Adaptation (GDA) to bridge graph-level distribution gaps between bulk and single-cell RNA-seq data. A dual-domain decoder further disentangles shared and modality-specific representations, preserving both general and unique biological signals. Benchmarking DAGFormer on ten independent scRNA-seq datasets demonstrated its superior performance compared to existing methods, underscoring its effectiveness and robustness in cancer drug response prediction.


  • Open Access

    NASNet-DTI: accurate drug-target interaction prediction using heterogeneous graphs and node adaptation.

    by Ningyu Zhong, Zhihua Du

    Drug-target interactions (DTIs) play a key role in drug development, and accurate prediction can significantly improve the efficiency of this process. Traditional experimental methods are reliable but time-consuming and laborious. With the rapid development of deep learning, many DTI prediction methods have emerged. However, most of these methods only focus on the intrinsic features of drugs and targets, while ignoring the relational features between them. In addition, existing graph-based DTI prediction methods often face the challenge of over-smoothing in graph neural networks (GNNs), which limits their prediction accuracy. To address these issues, we propose NASNet-DTI (Drug-target Interactions Based on Node Adaptation and Similarity Networks), a new framework designed to overcome these limitations. NASNet-DTI uses graph convolutional network to extract features from drug molecules and targets separately, and constructs heterogeneous networks to represent two types of nodes: drugs and targets. The edges in the network describe their multiple relationships: drug-drug, target-target, and drug-target. In the feature learning stage, NASNet-DTI adopts a node adaptive learning strategy to dynamically determine the optimal aggregation depth for each node. This ensures that each node can learn the most discriminative features, which effectively alleviates the over-smoothing problem and improves prediction accuracy. Experimental results show that NASNet-DTI significantly outperforms existing methods on multiple datasets, demonstrating its effectiveness and potential as a powerful tool to advance drug discovery and development.


  • Open Access

    ProtPhage: a deep learning framework for phage viral protein identification and functional annotation

    by Yuehua Ou, Qiyi Chen, Ningyu Zhong, Zhihua Du

    Phages, viruses that infect bacteria, offer a promising strategy against antibiotic-resistant pathogens. Phage viral proteins (PVPs) are essential for phage–host interactions, yet their identification and functional annotation remain challenging due to high sequence diversity, limited experimental data, and class imbalance. To address these issues, we propose ProtPhage, a novel framework that leverages the ProtT5 protein language model for richer sequence representation compared to traditional methods. Additionally, ProtPhage incorporates an asymmetric loss function to mitigate class imbalance, significantly improving the prediction of the minority class “minor capsid,” with an F1 score 33.07$\%$ higher than the best existing model. Extensive experiments demonstrate that ProtPhage outperforms current methods across multiple metrics, including accuracy, precision, recall, and F1 score. A case study on the Mycobacterium phage PDRPxv genome further validates its practical utility, while expanded experiments highlight its potential in phage–host prediction. By integrating advanced deep learning techniques, ProtPhage establishes a new standard for PVP identification and annotation, contributing to the broader field of computational phage biology.


  • Multi-view attention graph convolutional networks for the host prediction of phages

    by Lijia Ma, Peng Gao, Wenxiang Zhou, Qiuzhen Lin, Yuan Bai, Min Fang, Zhihua Du, Jianqiang Li


  • Open Access

    Prokaryotic virus host prediction with graph contrastive augmentaion

    by Zhi-Hua Du, Jun-Peng Zhong, Yun Liu, Jian-Qiang Li

    Prokaryotic viruses, also known as bacteriophages, play crucial roles in regulating microbial communities and have the potential for phage therapy applications. Accurate prediction of phage-host interactions is essential for understanding the dynamics of these viruses and their impacts on bacterial populations. Numerous computational methods have been developed to tackle this challenging task. However, most existing prediction models can be constrained due to the substantial number of unknown interactions in comparison to the constrained diversity of available training data. To solve the problem, we introduce a model for prokaryotic virus host prediction with graph contrastive augmentation (PHPGCA). Specifically, we construct a comprehensive heterogeneous graph by integrating virus-virus protein similarity and virus-host DNA sequence similarity information. As the backbone encoder for learning node representations in the virus-prokaryote graph, we employ LGCN, a state-of-the-art graph embedding technique. Additionally, we apply graph contrastive learning to augment the node representations without the need for additional labels. We further conducted two case studies aimed at predicting the host range of multi-species phages, helping to understand the phage ecology and evolution.


  • Hybrid Bayesian Optimization-Based Graphical Discovery for Methylation Sites Prediction

    by Ling-Yan Gu, Ting-Bo Chen, Jian-Qiang Li, Yu-An Huang, Zhi-Hua Du, Victor C.M. Leung, Jie Chen

    Protein methylation is one of the most important reversible post-translational modifications (PTMs), playing a vital role in the regulation of gene expression. Protein methylation sites serve as biomarkers in cardiovascular and pulmonary diseases, influencing various aspects of normal cell biology and pathogenesis. Nonetheless, the majority of existing computational methods for predicting protein methylation sites (PMSP) have been constructed based on protein sequences, with few methods leveraging the topological information of proteins. To address this issue, we propose an innovative framework for predicting Methylation Sites using Graphs (GraphMethySite) that employs graph convolution network in conjunction with Bayesian Optimization (BO) to automatically discover the graphical structure surrounding a candidate site and improve the predictive accuracy. In order to extract the most optimal subgraphs associated with methylation sites, we extend GraphMethySite by coupling it with a hybrid Bayesian optimization (together named GraphMethySite $^+$ ) to determine and visualize the topological relevance among amino-acid residues. We evaluated our framework on two extended protein methylation datasets, and empirical results demonstrate that it outperforms existing state-of-the-art methylation prediction methods.